Senate HELP Chair Cassidy Signals 340B Legislation Plans, ‘G6’ Senator Promises SUSTAIN Act Update Soon at NACHC Conference

Sen. Bill Cassidy (R-La.), chair of the Senate HELP Committee, addresses attendees at the NACHC P&I Conference.
Two influential U.S. senators—each with a distinct vision of 340B reform—told health center leaders yesterday that they remained committed to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospital Group Moves to Join Federal Case to Fight J&J’s Contested 340B Rebate Proposal

UMass Memorial Medical Center, along with 340B Health and one additional member hospital, filed a motion to intervene in a federal court case to argue against J&J's contested 340B rebate proposal.
A major hospital advocacy group and two of its members are seeking to intervene in a high-profile federal court case [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Safety-Net Hospital Group Urges HRSA to Block Sanofi 340B Rebate, Calling It More Harmful than J&J Model

Bruce Siegel, president and CEO of America's Essential Hospitals, strongly opposed Sanofi's 340B rebate model in a letter to HRSA.
A major hospital group is urging the Health Resources and Services Administration (HRSA) to intervene immediately against Sanofi’s proposed 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Panelists at Healthcare Purchaser Conference Link 340B to Higher Employer Healthcare Costs, Hospital Consolidation

Bret Jackson, president and CEO of the Michigan Economic Alliance, moderated a Nov. 19 panel with U.S. Rep. Victoria Spartz (R-Ind.), Thomas Johnson, executive director of ASAP 340B, and Ge Bai, Ph.D., professor of accounting and health policy at Johns Hopkins University.
The 340B program is increasing healthcare costs for employers and driving hospital consolidation, argued panelists at a recent healthcare purchaser [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

J&J Lawsuit to Test Trump Administration’s Stance on 340B Rebates

J&J sued HRSA on Nov. 12 for threatening enforcement action that led the drugmaker to withdraw its 340B rebate proposal.
Johnson & Johnson’s (J&J’s) lawsuit challenging the federal government’s opposition to 340B rebates will test whether the Trump administration is [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

PhRMA Pans Government’s Response to J&J’s 340B Rebate Proposal in Letter to HRSA Administrator

PhRMA sent an Oct. 11 letter to HRSA criticizing the agency's opposition to J&J's 340B rebate proposal.
Pharmaceutical Research and Manufacturers of America (PhRMA) expressed “serious concerns” with the federal government’s opposition to Johnson & Johnson’s (J&J’s) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Provider Groups, Key Federal Lawmaker Praise HRSA for Pressuring J&J to Drop 340B Rebate Proposal

U.S. Rep. Abigail Spanberger (D-Va.) and multiple 340B provider groups applauded HRSA for its response on J&J's 340B rebate proposal.
Multiple 340B provider groups have applauded the federal government for threatening “strong” enforcement actions that led Johnson & Johnson (J&J) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Maryland, Minnesota

Key filings and orders occurred in lawsuits challenging the 340B contract pharmacy access law in Missouri.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sen. Cassidy’s Letters to Drug Manufacturers Welcomed by Drug Industry Trade Group, Draw Skepticism from 340B Provider Advocates

The drug industry and 340B program advocates offered mixed reactions Monday to a key senator’s latest inquiries into drugmakers’ contract pharmacy restrictions as part of an ongoing congressional probe of the drug pricing program.
The drug industry and 340B program advocates offered mixed reactions Monday to a key senator’s latest inquiries into drugmakers’ contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospital Groups Urge HRSA to Take ‘Immediate Enforcement Action’ Against J&J’s Contested 340B Rebate Proposal

Two major hospital groups urged the government to take enforcement action against J&J's 340B rebate proposal.
Two major hospital advocacy groups are urging the federal agency that oversees the 340B program to “take immediate enforcement action” [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live